Deykin Aaron sold 895 shares of Upstream Bio (NASDAQ: UPB) at $5.49 per share on Sept. 16, 2026. The transaction left Aaron with 32,302 shares, while the sale represented about 2.7% of his previous holding in Upstream Bio.
Raymond Debbane holds 675,000 shares of Yarrow Bioscience, Inc. (NASDAQ: YARW), equal to 7.2% of the class. The ownership date is September 11, 2026. The stated purpose excludes seeking to change or influence control of Yarrow Bioscience.
Ameresco, Inc. (NYSE: AMRC) is an Engineering & Construction company. The sale occurred on 15 September 2026. Maltezos Louis P’s reported post-transaction holding was 33,628 shares. The reported price was $22.46 for each of the 592 shares sold. The transaction represented about 1.7% of …
Travere Therapeutics, Inc. (NASDAQ: TVTX) is a Pharmaceuticals: Major company. Cline Christopher R. its CHIEF FINANCIAL OFFICER, exercised options covering 20,000 shares at $17.44 per share on 15 September 2026. The exercise left him with 138,016 shares, representing about 14.5% of his resulting share …
Tyra Biosciences, Inc. (NASDAQ: TYRA) is a biotechnology company. RA Capital Management, L.P. purchased 9,078,529 derivative securities in Tyra Biosciences at $22.03 per share on Sep. 15, lifting its resulting position to 11,616,986 derivative securities.
Fuhrman Alan received 951 shares of Tyra Biosciences, Inc. (NASDAQ: TYRA) at $9.13 each on 15 September 2026, leaving him with 37,115 shares. The transaction represented about 2.6% of his resulting holding. Alan is Tyra Biosciences’ Chief Financial Officer.
Rueb Yuliya received 2,925 shares of Tyra Biosciences, Inc. (NASDAQ: TYRA) at $9.13 per share on 15 September 2026. The award left Yuliya with 11,258 Tyra Biosciences shares, while the transaction represented about 26.0% of the resulting holding.
Halozyme Therapeutics director Posard Matthew L. sold 18,996 shares on 16 September 2026 through four transactions, with prices ranging from $106.13 to $108.99 per share. His reported ownership after the sales was 58,839 shares. The disclosed transaction represented about 24.4% of his prior shares …
Quanterix Award Adds 260,315 Derivative Securities
Sikri Vishal was awarded 257,731 shares of Myriad Genetics Inc at $0 per share. The ownership record also lists 93,493 shares held directly or indirectly by Vishal.